This limitation hampers the ability to investigate ancestry-related biological differences, as opposed to differences due to social determinants of health, in AD risk or to determine whether the APOE4 risk in AD dementia is really attenuated in AFR or the lower risk of dementia is related to increased amounts of non-AD neuropathology in individuals with AFR. This evidence concerns the gene APOE and Alzheimer disease.